Selective Vulnerability of Dopaminergic Neurons to Microtubule Depolymerization*

Parkinson disease (PD) is characterized by the specific degeneration of dopaminergic (DA) neurons in substantia nigra and has been linked to a variety of environmental and genetic factors. Rotenone, an environmental PD toxin, exhibited much greater toxicity to DA neurons in midbrain neuronal cultures than to non-DA neurons. The effect was significantly decreased by the microtubule-stabilizing drug taxol and mimicked by microtubule-depolymerizing agents such as colchicine or nocodazole. Microtubule depolymerization disrupted vesicular transport along microtubules and caused the accumulation of dopamine vesicles in the soma. This led to increased oxidative stress due to oxidation of cytosolic dopamine leaked from vesicles. Inhibition of dopamine metabolism significantly reduced rotenone toxicity. Thus, our results suggest that microtubule depolymerization induced by PD toxins such as rotenone plays a key role in the selective death of dopaminergic neurons.

[1]  D. Sulzer,et al.  Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics , 2003, Trends in Neurosciences.

[2]  M. Zigmond,et al.  Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Jian Feng,et al.  Parkin Binds to α/β Tubulin and Increases their Ubiquitination and Degradation , 2003, The Journal of Neuroscience.

[4]  A. Levey,et al.  Dopamine transporters and neuronal injury. , 1999, Trends in pharmacological sciences.

[5]  L. Goldstein,et al.  Do Disorders of Movement Cause Movement Disorders and Dementia? , 2003, Neuron.

[6]  H. Joshi,et al.  Differential utilization of beta-tubulin isotypes in differentiating neurites , 1989, The Journal of cell biology.

[7]  J. Shih,et al.  Monoamine oxidase: from genes to behavior. , 1999, Annual review of neuroscience.

[8]  E. Richfield,et al.  The Nigrostriatal Dopaminergic System as a Preferential Target of Repeated Exposures to Combined Paraquat and Maneb: Implications for Parkinson's Disease , 2000, The Journal of Neuroscience.

[9]  P. Greengard,et al.  Spinophilin regulates the formation and function of dendritic spines. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  C. Moraes,et al.  Titrating the Effects of Mitochondrial Complex I Impairment in the Cell Physiology* , 1999, The Journal of Biological Chemistry.

[11]  A single-subunit NADH-quinone oxidoreductase renders resistance to mammalian nerve cells against complex I inhibition. , 2003 .

[12]  Donato A Di Monte,et al.  The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins? , 2003, The Lancet Neurology.

[13]  P Riederer,et al.  Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains , 1991, Journal of neurochemistry.

[14]  Jian Feng,et al.  Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis. , 2004, Human molecular genetics.

[15]  G. Cappelletti,et al.  MICROTUBULE ASSEMBLY IS DIRECTLY AFFECTED BY MPP+IN VITRO , 2001, Cell biology international.

[16]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]／Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[17]  G. Borisy.  A rapid method for quantitative determination of microtubule protein using DEAE-cellulose filters. , 1972, Analytical biochemistry.

[18]  W. Chen,et al.  Dynamic Storage of Dopamine in Rat Brain Synaptic Vesicles In Vitro , 1995, Journal of neurochemistry.

[19]  Richard H. Scheller,et al.  SNARE-mediated membrane fusion , 2001, Nature Reviews Molecular Cell Biology.

[20]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[21]  G. R. Williams,et al.  Inhibition of electron and energy transfer in mitochondria. I. Effects of Amytal, thiopental, rotenone, progesterone, and methylene glycol. , 1963, The Journal of biological chemistry.

[22]  R. Himes,et al.  Brain tubulin polymerization in the absence of "microtubule-associated proteins". , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Langston,et al.  Parkinson's disease: current and future challenges. , 2002, Neurotoxicology.

[24]  R. Edwards,et al.  The role of vesicular transport proteins in synaptic transmission and neural degeneration. , 1997, Annual review of neuroscience.

[25]  G. Cappelletti,et al.  Influence of MPP+ on the state of tubulin polymerisation in NGF‐differentiated PC12 cells , 1999, Journal of neuroscience research.

[26]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[27]  Todd B. Sherer,et al.  Mechanism of Toxicity in Rotenone Models of Parkinson's Disease , 2003, The Journal of Neuroscience.

[28]  R. Himes,et al.  Rotenone inhibition of tubulin self-assembly. , 1978, Biochimica et biophysica acta.

[29]  R. Doherty,et al.  An Improved DEAE‐Cellulose Filter Assay for Colchicine Binding Protein (During Mouse Brain Development) , 1980, Journal of neurochemistry.

[30]  B. Brinkley,et al.  Rotenone inhibition of spindle microtubule assembly in mammalian cells. , 1974, Experimental cell research.

[31]  D. Wilkin,et al.  Neuron , 2001, Brain Research.

[32]  Jian Feng,et al.  Parkin is recruited to the centrosome in response to inhibition of proteasomes , 2003, Journal of Cell Science.

[33]  D. Goldstein,et al.  Leaky Catecholamine Stores: Undue Waste or a Stress Response Coping Mechanism? , 2004, Annals of the New York Academy of Sciences.